Ebola Virus Disease: Progress So Far in the Management of the Disease

Engwa, G.A. (2016) Ebola Virus Disease: Progress So Far in the Management of the Disease. Current Topics in Tropical Emerging Diseases and Travel Medicine.

Text EBOLA VIRUS DISEASE CHAPTER.pdf Download (1MB)

Abstract

Ebola virus disease is one of the most deadly emerging infectious diseases in the world which causes severe haemorrhagic fever, with a mortality rate of 50–90%. Following the largest outbreak in West Africa in 2014 which was the most deadly of all time challenging global health, so much concern has been tilted towards the management of the disease. Some of the major global challenges that prolonged and escalated the gravity of the 2014 outbreak were the lack of prompt, reliable and affordable diagnostic tools, but most importantly no specific treatment and vaccines were available to manage the infection. Though certain non-licensed experimental drugs as well as vaccines were introduced during the 2014 outbreak that contributed towards the control of the epidemic, their efficacy was yet to be confirmed in randomized trials. Presently, a few rapid diagnostic test kits have been approved by FDA and WHO. Also, several experimental drugs and vaccines are undergoing randomized clinical trials with a few currently at phase III. Thus, it is our hope that most of these drugs and vaccines will be available in future to better manage re-emerging Ebola infections or outbreaks.

Item Type:	Article
Subjects:	L Education > L Education (General) Q Science > Q Science (General)
Divisions:	Faculty of Natural and Applied Sciences
Depositing User:	miss ifeoma agbo
Date Deposited:	18 Apr 2019 11:45
Last Modified:	18 Apr 2019 11:45
URI:	http://eprints.gouni.edu.ng/id/eprint/1170

Actions (login required)

View Item